These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29697470)

  • 1. Update on techniques to prevent infections associated with prostate needle biopsy.
    Fontana M; Boeri L; Montanari E
    Curr Opin Urol; 2018 Jul; 28(4):392-397. PubMed ID: 29697470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprophylaxis during transrectal prostate needle biopsy: critical analysis through randomized clinical trial.
    Elshal AM; Atwa AM; El-Nahas AR; El-Ghar MA; Gaber A; Elsawy E; Hashem A; Farag Y; Farg H; Elsorougy A; Fouda M; Nabeeh H; Mosbah A
    World J Urol; 2018 Nov; 36(11):1845-1852. PubMed ID: 29736609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
    Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
    Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Antimicrobial Prophylaxis Does Not Always Prevent Sepsis after Transrectal Prostate Biopsy.
    Jiang P; Liss MA; Szabo RJ
    J Urol; 2018 Aug; 200(2):361-368. PubMed ID: 29574110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Targeted" prophylaxis: Impact of rectal swab culture-directed prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy.
    Singh P; Kumar A; Yadav S; Prakash L; Nayak B; Kumar R; Kapil A; Dogra PN
    Investig Clin Urol; 2017 Sep; 58(5):365-370. PubMed ID: 28868509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective randomized comparative study of targeted versus empirical prophylactic antibiotics in the prevention of infective complications following transrectal ultrasound-guided prostate biopsy.
    Doherty AF; Ikuerowo SO; Jeje EA; Ibrahim NA; Ojongbede OL; Mutiu WB; Omisanjo OA; Abolarinwa AA
    Ann Afr Med; 2019; 18(3):132-137. PubMed ID: 31417013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis.
    Roberts MJ; Scott S; Harris PN; Naber K; Wagenlehner FME; Doi SAR
    World J Urol; 2018 Mar; 36(3):323-330. PubMed ID: 29288398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Augmented Antimicrobial Prophylaxis and Rectal Swab Culture-guided Targeted Prophylaxis on the Risk of Sepsis Following Transrectal Prostate Biopsy.
    Hadjipavlou M; Eragat M; Kenny C; Pantelidou M; Mulhem W; Wood C; Dall'Antonia M; Hammadeh MY
    Eur Urol Focus; 2020 Jan; 6(1):95-101. PubMed ID: 31928632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended-spectrum β-lactamase in the rectal flora of patients undergoing transrectal prostate biopsy: a study of the prevalence in a major metropolitan hospital.
    Sewell J; Chow K; De Sousa A; Sapre N; Norris B; Namdarian B; Sinickas V; Huang JG; Anderson P
    BJU Int; 2019 May; 123 Suppl 5():43-46. PubMed ID: 31012990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Povidone Iodine Rectal Preparation at Time of Prostate Needle Biopsy is a Simple and Reproducible Means to Reduce Risk of Procedural Infection.
    Raman JD; Lehman KK; Dewan K; Kirimanjeswara G
    J Vis Exp; 2015 Sep; (103):. PubMed ID: 26436913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Better understanding of minimizing infectious complications after transrectal prostate biopsy.
    Gettman MT
    Eur Urol; 2012 Sep; 62(3):460-1. PubMed ID: 22648058
    [No Abstract]   [Full Text] [Related]  

  • 12. Povidone-iodine rectal cleansing and targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound-guided prostate biopsy are associated with reduced incidence of postoperative infectious complications.
    Ryu JW; Jung SI; Ahn JH; Hwang EC; Yu HS; Kang TW; Kwon DD; Park K; Kim JW
    Int Urol Nephrol; 2016 Nov; 48(11):1763-1770. PubMed ID: 27495324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis?
    Carignan A; Roussy JF; Lapointe V; Valiquette L; Sabbagh R; Pépin J
    Eur Urol; 2012 Sep; 62(3):453-9. PubMed ID: 22575912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial.
    Hu JC; Assel M; Allaf ME; Ehdaie B; Vickers AJ; Cohen AJ; Ristau BT; Green DA; Han M; Rezaee ME; Pavlovich CP; Montgomery JS; Kowalczyk KJ; Ross AE; Kundu SD; Patel HD; Wang GJ; Graham JN; Shoag JE; Ghazi A; Singla N; Gorin MA; Schaeffer AJ; Schaeffer EM
    Eur Urol; 2024 Jul; 86(1):61-68. PubMed ID: 38212178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of combined prophylactic use of levofloxacin and isepamicin for transrectal prostate needle biopsy: A retrospective single-center study.
    Nakagawa R; Shigehara K; Aoyama S; Urata S; Ofude M; Miyagi T; Nakashima T; Izumi K; Mizokami A
    J Infect Chemother; 2019 May; 25(5):337-340. PubMed ID: 30718193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical comparison of the efficacy of three different bowel preparation methods on the infectious complications following transrectal ultrasonography-guided prostate biopsy in nursing practice.
    Zhang XH; Jia Y; Guo WH; Ma YR; Yang J; Zhang Y; Hou SC; Zhang CC
    J Clin Nurs; 2018 Jul; 27(13-14):2583-2589. PubMed ID: 28401738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stemming the Tide: Infectious Complications After Prostate Biopsy.
    Black P
    World J Urol; 2015 Jun; 33(6):893, 896-7. PubMed ID: 25985751
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: A prospective multicenter study.
    Chung HS; Hwang EC; Yu HS; Jung SI; Lee SJ; Lim DH; Cho WJ; Choe HS; Lee SJ; Park SW
    Int J Urol; 2018 Mar; 25(3):278-283. PubMed ID: 29241300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy--should we reassess our practices for antibiotic prophylaxis?
    Steensels D; Slabbaert K; De Wever L; Vermeersch P; Van Poppel H; Verhaegen J
    Clin Microbiol Infect; 2012 Jun; 18(6):575-81. PubMed ID: 21958149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Infectious Complications after Targeted Prophylaxis for Prostate Needle Biopsy.
    Papagiannopoulos D; Abern M; Wilson N; O'Block N; Raff L; Coogan C; Latchamsetty KC
    J Urol; 2018 Jan; 199(1):155-160. PubMed ID: 28807644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.